Deactivation of implantable cardioverter-defibrillators: Results of patient surveys

Europace

Volumn 15, Issue 7, 2013, Pages 963-969

  Herman, Dalibor ^a   Stros, Petr ^a   Curila, Karol ^a   Kebza, Vladimir ^b   Osmancik, Pavel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

End of life; Heart failure; ICD

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTPATIENT; PAROXYSMAL HEART ATRIUM FIBRILLATION; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIMARY PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; RECIPIENT; SECONDARY PREVENTION; SINUS RHYTHM; SUDDEN CARDIAC DEATH; TERMINAL CARE; TREATMENT DURATION;

END-OF-LIFE; HEART FAILURE; ICD;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT EDUCATION AS TOPIC; PRIMARY PREVENTION; QUESTIONNAIRES; SECONDARY PREVENTION; TERMINAL CARE; TREATMENT OUTCOME;

EID: 84879586550     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus432     Document Type: Article

References (18)

1. Lane RE, Cowie MR, Chow AW. Prediction and prevention of sudden cardiac death in heart failure. Heart 2005;91:674-80.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
4. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-235.
5. Adams KF, Lindenfeld JA, Arnold JMO, Baker DW, Barnard DH, Baugman KL et al. Heart Failure Society Of A. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006;12:e1-2.
6. Mueller PS, Hook CC, Hayes DL. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc 2003;78:959-63.
7. Marinskis G, van Erven L. Deactivation of implanted cardioverter- defibrillators at the end of life: results of the EHRA survey. Europace 2010;12:1176-7.
8. Kirkpatrick JN, Gottlieb M, Sehgal P, Patel R, Verdino RJ. Deactivation of implan-table cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol 2012;109:91-4.
9. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010;16: e1-194.
10. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-22.
11. Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M et al. 'That's like an act of suicide' patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008;23(Suppl 1): 7-12.
12. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007;154: 260-6.
13. Schulman-Green DJ, Naik AD, Bradley EH, McCorkle R, Bogardus ST. Goal setting as a shared decision making strategy among clinicians and their older patients. Patient Educ Couns 2006;63:145-51.
14. Morrison RS, Chichin E, Carter J, Burack O, Lantz M, Meier DE. The effect of a social work intervention to enhance advance care planning documentation in the nursing home. J Am Geriatr Soc 2005;53:290-4.
15. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141:835-8.
16. Ngai DKHJ. Turning off the implantable cardioverter defibrillator to prevent pre-death electrical shocks: an exercise and right in the refusal of medical treatment. Internet J Law Healthc Ethics 2011;7: 10.5580/cb5.
17. Kapa S, Mueller PS, Hayes DL, Asirvatham SJ. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc 2010;85: 981-90.
18. Sherazi S, Daubert JP, Block RC, Jeevanantham V, Abdel-Gadir K, DiSalle MR et al. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc 2008;83: 1139-41.